What topical or oral antifungal therapy is appropriate for a 47-year-old woman with suspected tinea corporis of the lower legs, given her type 2 diabetes, hypothyroidism, obesity, elevated liver enzymes, and fatty liver disease?

Topical Terbinafine 1% Cream for 1-2 Weeks is the Most Appropriate First-Line Treatment

For this patient with suspected tinea corporis (ringworm) of the lower legs that has failed OTC antifungal therapy, I recommend topical terbinafine 1% cream applied once daily for 1-2 weeks, with consideration for oral terbinafine 250 mg daily for 2-4 weeks if topical therapy fails or if the infection is extensive. 1

Clinical Reasoning

Why Topical Therapy First?

The patient presents with localized lower extremity lesions that have been present for 2-3 months with progressive enlargement and pruritus. While she reports trying an OTC antifungal without improvement, the specific agent, duration, and adherence are unknown. Topical terbinafine 1% is superior to other topical agents and achieves mycological cure rates of approximately 94% when applied daily for 1 week 1. This is significantly more effective than the clotrimazole or miconazole products she likely tried over-the-counter.

When to Consider Oral Therapy

Given her comorbidities—particularly elevated liver enzymes and fatty liver disease—oral antifungal therapy requires careful consideration. However, oral therapy becomes necessary if:

• Topical therapy fails after 2-4 weeks of appropriate use
• Lesions are extensive or involve multiple body sites
• Hyperkeratotic changes are present
• The patient cannot adequately apply topical medication to all affected areas 2

Specific Treatment Algorithm

Step 1: Confirm Diagnosis

Before initiating treatment, obtain KOH preparation or fungal culture from scale scraped from the active border of lesions. However, it is reasonable to begin empiric therapy while awaiting results given the classic presentation 3.

Step 2: Initial Topical Treatment

• Terbinafine 1% cream applied once daily to affected areas and 2-3 cm beyond the visible border
• Duration: 1-2 weeks 1
• Alternative: Naftifine 1% cream if terbinafine unavailable (similar efficacy) 4

Step 3: If Topical Therapy Fails

Oral terbinafine 250 mg once daily for 2-4 weeks 3, 5

This is preferred over oral itraconazole or fluconazole in this patient because:

• Lower hepatotoxicity risk: Critical given her elevated liver enzymes and fatty liver disease
• Minimal drug interactions: Unlike itraconazole (potent CYP3A4 inhibitor), terbinafine has low interaction potential 6
• Superior efficacy for Trichophyton species: The most common cause of tinea corporis 1, 3

Important Caveats for This Patient

Liver Disease Considerations

Monitor liver enzymes before and during oral antifungal therapy. While terbinafine is generally safe, rare cases of liver failure have occurred, typically in patients with pre-existing liver disease 1. Her baseline elevated liver enzymes and fatty liver disease increase this risk, though it remains low. Check AST/ALT at baseline and at 4-6 weeks if using oral therapy.

Diabetes Impact

Her Type 2 diabetes is a risk factor for more extensive and recalcitrant fungal infections 1. Ensure adequate glycemic control, as hyperglycemia impairs immune function and promotes fungal growth. The correlation between diabetes and elevated liver enzymes is well-established 7, 8, making her liver function monitoring even more critical.

Why Higher Doses Don't Help

Do not use terbinafine 500 mg daily—a recent study showed no additional benefit over 250 mg daily for tinea corporis/cruris, with overall poor cure rates at both doses after 4 weeks 5. This suggests the current dermatophyte strains may have reduced susceptibility, making adequate treatment duration and combination with topical therapy more important than dose escalation.

Alternative Agents (If Terbinafine Contraindicated)

If oral therapy is needed but terbinafine is contraindicated:

1. Itraconazole 100 mg daily for 15 days: Effective for both Trichophyton and Microsporum species with 78% response rates 9, but has significant drug interaction potential and requires monitoring in liver disease
2. Fluconazole 150 mg weekly for 2-4 weeks: Less data for tinea corporis, but 95% cure rates reported 10; also requires hepatic monitoring

What NOT to Do

• Avoid topical steroid-antifungal combinations as initial therapy—while they may provide faster symptomatic relief, they can mask the infection and are not recommended in guidelines despite some studies showing higher short-term clinical cure rates 4
• Do not use griseofulvin—it is less effective against Trichophyton species and requires 6-8 weeks of treatment 3
• Avoid oral therapy without attempting appropriate topical treatment first given her liver disease

Follow-Up Strategy

• Reassess at 2 weeks: If no improvement with topical therapy, transition to oral terbinafine
• Repeat KOH/culture if initially positive to confirm mycological cure
• If clinical improvement but persistent positive mycology, continue current therapy for an additional 2-4 weeks 3